Q1 2019

Source filing unavailable

Q1 2019 · —

Revenue—

Net Income

-$9.57M

N/M vs Q1 2018

EPS Diluted

-$8.69

N/M vs Q1 2018

Operating Income-$10,094,000—

Operating Cash Flow-$9,785,000—

Free Cash Flowderived-$10,391,000—

Same quarter

Metric	Q1 2019	Q1 2018
Net Income	-$9.57M	-$5.74M
EPS Diluted	-$8.69	-$6.91

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR